
Opinion|Videos|July 23, 2024
NCCN Recommendations by PD-L1 Expression Level
A panel of experts discuss how the NCCN guideline recommendations differ for patients with and without PD-L1 expression.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How do the NCCN guideline recommendations differ for patients without PD-L1 expression (<1%) compared with those with low (1%-49%) or high (≥50%) expression?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
Measles Outbreaks Cause Financial, Public Health Burden in US
3
Real-World Data Key to Optimizing CAR T-Cell Therapy Delivery, Outcomes
4
New PBM Laws Seek to Protect Independent Pharmacies but Could Raise Costs, Limit Patient Access
5














































